Skip to main content

Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study

2024-10-15 08:23:49

Artistic rendition of diabetic eye disease highlighting vascular changes (i.e., retinal neovascularization) observed in patients with proliferative diabetic retinopathy. Credit: Isabella S. Sodhi, McDonogh School

News from our full member the Wilmer Eye Institute – Johns Hopkins

Research from Akrit Sodhi and colleagues shows that an experimental drug may prevent or slow vision loss in people with diabetes.

More information here!

Source and image: Wilmer Eye Institute – Johns Hopkins

More news

Patients regain sight after being first to receive retinal tissue engineered from stem cells

The first patients to receive a new treatment derived from stem cells for people with wet age-related macular degeneration (AMD) have regained reading vision. The results of this ground-breaking clinical […]

Cao Thang Eye Hospital in Vietnam: Renewed WAEH Membership!

The World Association of Eye Hospitals warmly congratulates Cao Thang Eye Hospital from Vietnam with the renewal of their associate membership of the WAEH! We are looking forward to the […]

New Associate WAEH Member: Saigon Eye Hospital!

The World Association of Eye Hospitals warmly congratulates Saigon Eye Hospital from Ho Chi Minh City, Vietnam, with their associate membership of the WAEH! We are looking forward to the […]

News from our member L V Prasad Eye Institute

50k Corneal Transplants This month, L V Prasad Eye Institute achieved a significant milestone when we touched the mark of performing 50,000th corneal transplant at our Institute. It is possibly […]

New Associate Member Alert: Shenyang Sinqi Eye Hospital

The World Association of Eye Hospitals warmly congratulates Shenyang Sinqi Eye Hospital from China with their associate membership of the WAEH! We are looking forward to the valuable cooperation ahead! […]